Corient Private Wealth LLC Sells 10,106 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Corient Private Wealth LLC lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 18.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 45,520 shares of the company’s stock after selling 10,106 shares during the quarter. Corient Private Wealth LLC’s holdings in Henry Schein were worth $3,150,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in HSIC. Versant Capital Management Inc increased its stake in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after acquiring an additional 335 shares during the period. Venturi Wealth Management LLC increased its stake in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC increased its stake in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after acquiring an additional 323 shares during the period. Smartleaf Asset Management LLC increased its stake in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after acquiring an additional 143 shares during the period. Finally, City State Bank bought a new stake in Henry Schein in the fourth quarter valued at about $55,000. Institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on HSIC. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Barrington Research restated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company started coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target on the stock. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Trading Down 1.5 %

Shares of NASDAQ HSIC opened at $69.39 on Friday. The company’s 50 day simple moving average is $74.82 and its 200 day simple moving average is $72.61. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The firm has a market capitalization of $8.62 billion, a P/E ratio of 28.56, a P/E/G ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the company posted $0.66 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. On average, analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.